SciDev.Net partnered with the London School of Economics (LSE) and Museu da Vida (Brazil) to examine science communication around the world: journalists' background, workload, and opinions on science communication, work environment and capacity building needs.
Aaron Kesselheim and colleagues investigate conflict of interest disclosures in articles authored by physicians and scientists identified in whistleblower complaints alleging illegal off-label marketing by pharmaceutical companies.
Two paragraphs in its introductory section have blighted an article on stem cell research. Graham Parker, editor of Stem Cells and Development, told the science journal Nature that his publication was retracting the study by scientists at Britain
The high costs of publishing traditional journals open the door for sponsored content In April 2009, an online life sciences magazine, The-Scientist.com carried a curious story about a journal called The Australasian Journal of Bone and Medicine that was published in the early part of the century. The journal published by the reputed publisher Elsevier reprinted articles from
Used phony journals to push Vioxx pharma giant Merck has been accused of using unscrupulous methods, including publication of fake journals, to promote its anti-arthritis drug Vioxx. The evidence against Merck was presented before an Australian court in May after it began hearing a four-year-old lawsuit. Merck paid a well-known academic publisher, Elsevier, to compile favourable
NEW DELHI: Massachusetts Institute of Technology (MIT) will bring out its prestigious scientific journal, Technology Review, in India in association with Cybermedia publishing house.
Investments in the research and development (r&d) in India has grown from Rs 760.5 crore in 1980 to Rs 24,200 crore (as per 2008-2009 budget allocation). This is 0.8 per cent of the gdp From 1996 to 2006, expenditure has increased by 180 per cent. But the number of research publications increased by only 95 per cent
